LANTHEUS HOLDINGS INC (LNTH)

US5165441032 - Common Stock

81.48  +0.35 (+0.43%)

After market: 81.48 0 (0%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to LNTH. LNTH was compared to 190 industry peers in the Health Care Equipment & Supplies industry. LNTH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LNTH is evaluated to be cheap and growing strongly. This does not happen too often! With these ratings, LNTH could be worth investigating further for value and growth and quality investing!.



7

1. Profitability

1.1 Basic Checks

In the past year LNTH was profitable.
LNTH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: LNTH reported negative net income in multiple years.
Each year in the past 5 years LNTH had a positive operating cash flow.

1.2 Ratios

The Return On Assets of LNTH (25.15%) is better than 98.95% of its industry peers.
LNTH has a Return On Equity of 48.71%. This is amongst the best in the industry. LNTH outperforms 99.47% of its industry peers.
Looking at the Return On Invested Capital, with a value of 23.65%, LNTH belongs to the top of the industry, outperforming 98.95% of the companies in the same industry.
Industry RankSector Rank
ROA 25.15%
ROE 48.71%
ROIC 23.65%
ROA(3y)4.55%
ROA(5y)3.98%
ROE(3y)10.32%
ROE(5y)11.2%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 33.73%, LNTH belongs to the top of the industry, outperforming 98.95% of the companies in the same industry.
LNTH's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 34.74%, LNTH belongs to the top of the industry, outperforming 98.95% of the companies in the same industry.
LNTH's Operating Margin has improved in the last couple of years.
LNTH has a Gross Margin of 64.03%. This is in the better half of the industry: LNTH outperforms 64.21% of its industry peers.
LNTH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 34.74%
PM (TTM) 33.73%
GM 64.03%
OM growth 3Y69.82%
OM growth 5Y8.97%
PM growth 3YN/A
PM growth 5Y16.4%
GM growth 3Y7.77%
GM growth 5Y1.45%

8

2. Health

2.1 Basic Checks

LNTH has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, LNTH has less shares outstanding
The number of shares outstanding for LNTH has been increased compared to 5 years ago.
LNTH has a better debt/assets ratio than last year.

2.2 Solvency

LNTH has an Altman-Z score of 6.21. This indicates that LNTH is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.21, LNTH belongs to the best of the industry, outperforming 81.58% of the companies in the same industry.
The Debt to FCF ratio of LNTH is 2.75, which is a good value as it means it would take LNTH, 2.75 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.75, LNTH belongs to the best of the industry, outperforming 86.32% of the companies in the same industry.
A Debt/Equity ratio of 0.59 indicates that LNTH is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.59, LNTH is not doing good in the industry: 69.47% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 2.75
Altman-Z 6.21
ROIC/WACC2.64
WACC8.96%

2.3 Liquidity

LNTH has a Current Ratio of 4.84. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
LNTH has a better Current ratio (4.84) than 67.89% of its industry peers.
A Quick Ratio of 4.55 indicates that LNTH has no problem at all paying its short term obligations.
LNTH has a Quick ratio of 4.55. This is in the better half of the industry: LNTH outperforms 71.05% of its industry peers.
Industry RankSector Rank
Current Ratio 4.84
Quick Ratio 4.55

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.65% over the past year.
Measured over the past years, LNTH shows a very strong growth in Earnings Per Share. The EPS has been growing by 45.36% on average per year.
Looking at the last year, LNTH shows a very strong growth in Revenue. The Revenue has grown by 32.97%.
LNTH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.43% yearly.
EPS 1Y (TTM)36.65%
EPS 3Y121.92%
EPS 5Y45.36%
EPS Q2Q%14.97%
Revenue 1Y (TTM)32.97%
Revenue growth 3Y56.32%
Revenue growth 5Y30.43%
Sales Q2Q%23%

3.2 Future

Based on estimates for the next years, LNTH will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.62% on average per year.
LNTH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.57% yearly.
EPS Next Y15.65%
EPS Next 2Y4.43%
EPS Next 3Y6.6%
EPS Next 5Y17.62%
Revenue Next Year17.94%
Revenue Next 2Y10.41%
Revenue Next 3Y11.24%
Revenue Next 5Y16.57%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.63, the valuation of LNTH can be described as correct.
LNTH's Price/Earnings ratio is rather cheap when compared to the industry. LNTH is cheaper than 94.74% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.73, LNTH is valued rather cheaply.
A Price/Forward Earnings ratio of 11.99 indicates a reasonable valuation of LNTH.
Based on the Price/Forward Earnings ratio, LNTH is valued cheaper than 93.68% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of LNTH to the average of the S&P500 Index (20.21), we can say LNTH is valued slightly cheaper.
Industry RankSector Rank
PE 12.63
Fwd PE 11.99

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 93.16% of the companies listed in the same industry.
86.32% of the companies in the same industry are more expensive than LNTH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 27.54
EV/EBITDA 10.22

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of LNTH may justify a higher PE ratio.
PEG (NY)0.81
PEG (5Y)0.28
EPS Next 2Y4.43%
EPS Next 3Y6.6%

0

5. Dividend

5.1 Amount

No dividends for LNTH!.
Industry RankSector Rank
Dividend Yield N/A

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (6/20/2024, 3:04:30 PM)

After market: 81.48 0 (0%)

81.48

+0.35 (+0.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.65B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 12.63
Fwd PE 11.99
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.81
PEG (5Y)0.28
Profitability
Industry RankSector Rank
ROA 25.15%
ROE 48.71%
ROCE
ROIC
ROICexc
ROICexgc
OM 34.74%
PM (TTM) 33.73%
GM 64.03%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.84
Quick Ratio 4.55
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)36.65%
EPS 3Y121.92%
EPS 5Y
EPS Q2Q%
EPS Next Y15.65%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)32.97%
Revenue growth 3Y56.32%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y